A long-acting injectable exenatide-loaded hydrogel has shown promise in preclinical research for minimizing initial burst release, achieving steady, sustained drug delivery over 1 week, and improving glucose tolerance and weight management
Over one year, liraglutide did not significantly improve the primary endpoint (change in cerebral glucose metabolic rate in certain brain regions), but secondary endpointsincluding brain volume loss, and cognitive measuresshowed benefit: ~50% less loss in several brain regions compared to placebo
Maintaining the weight loss achieved through these treatments is another key benefit
Systemic tissue-repair dosing runs 1 mg to 2.5 mg subcutaneously, three times per week
Vegetable Magnesium Stearate Warnings If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use